Literature DB >> 1584463

Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology.

P L Lantos1, P J Luthert, D Hanger, B H Anderton, M Mullan, M Rossor.   

Abstract

The cytoskeletal pathology of a patient with familial Alzheimer's disease (AD) associated with the probably causal amyloid precursor protein (APP) codon 717 Val----Ile mutation is described. In addition to moderately extensive beta A4 protein deposition within the substance of the brain and in blood vessel walls (congophilic angiopathy), there was abundant cytoskeletal pathology in the form of neurofibrillary tangles, plaque neurites and neuropil threads. Interestingly, plentiful cortical and subcortical Lewy bodies were also seen. In order to compare the cytoskeletal pathology in this case with that seen in sporadic cases of AD we (1) studied the immunohistochemical profile of the amyloid and cytoskeletal pathology with antibodies to beta A4 protein, tau, phosphorylated neurofilament epitopes and ubiquitin and (2) performed a biochemical fractionation and Western blot analysis for the abnormally phosphorylated form of tau (A68) characteristically seen in AD. No substantial difference between the familial case and sporadic cases could be found. We conclude that it is now reasonable to hypothesise that an abnormality in APP metabolism is responsible not only for the deposition of beta A4 protein, but also for the range of cytoskeletal pathology, typical of AD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1584463     DOI: 10.1016/0304-3940(92)90408-y

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

Review 1.  Alzheimer's disease.

Authors:  M Rossor
Journal:  Postgrad Med J       Date:  1992-07       Impact factor: 2.401

2.  Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine-->serine (L250S) substitution at codon 250 of the presenilin 1 gene.

Authors:  R J Harvey; D Ellison; J Hardy; M Hutton; P K Roques; J Collinge; N C Fox; M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

3.  Antibodies to presenilin proteins detect neurofibrillary tangles in Alzheimer's disease.

Authors:  G M Murphy; L S Forno; W G Ellis; D Nochlin; E Levy-Lahad; P Poorkaj; T D Bird; Z Jiang; B Cordell
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

4.  Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.

Authors:  D M Mann; T Iwatsubo; Y Ihara; N J Cairns; P L Lantos; N Bogdanovic; L Lannfelt; B Winblad; M L Maat-Schieman; M N Rossor
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

5.  Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation.

Authors:  S M Greenberg; E H Koo; D J Selkoe; W Q Qiu; K S Kosik
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

6.  Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.

Authors:  C F Lippa; H Fujiwara; D M Mann; B Giasson; M Baba; M L Schmidt; L E Nee; B O'Connell; D A Pollen; P St George-Hyslop; B Ghetti; D Nochlin; T D Bird; N J Cairns; V M Lee; T Iwatsubo; J Q Trojanowski
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

Review 7.  Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD.

Authors:  Mario F Mendez
Journal:  Arch Med Res       Date:  2012-11-21       Impact factor: 2.235

8.  The pathogenesis of Alzheimer's disease: a reevaluation of the "amyloid cascade hypothesis".

Authors:  R A Armstrong
Journal:  Int J Alzheimers Dis       Date:  2011-02-07

Review 9.  Insights into Alzheimer disease pathogenesis from studies in transgenic animal models.

Authors:  Evelin L Schaeffer; Micheli Figueiro; Wagner F Gattaz
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  Differences between Early and Late-Onset Alzheimer's Disease in Neuropsychological Tests.

Authors:  Francisca Sá; Paula Pinto; Catarina Cunha; Raquel Lemos; Liliana Letra; Mário Simões; Isabel Santana
Journal:  Front Neurol       Date:  2012-05-14       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.